Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Nemo-Like Kinase Antikörper

Der Kaninchen Monoklonal Anti-Nemo-Like Kinase-Antikörper wurde für WB und IHC validiert. Er ist geeignet, Nemo-Like Kinase in Proben von Human zu detektieren.
Produktnummer ABIN7268846

Kurzübersicht für Nemo-Like Kinase Antikörper (ABIN7268846)

Target

Alle Nemo-Like Kinase (NLK) Antikörper anzeigen
Nemo-Like Kinase (NLK)

Reaktivität

  • 73
  • 35
  • 12
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 74
  • 4
Kaninchen

Klonalität

  • 74
  • 4
Monoklonal

Konjugat

  • 28
  • 6
  • 5
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Nemo-Like Kinase Antikörper ist unkonjugiert

Applikation

  • 70
  • 31
  • 26
  • 26
  • 18
  • 12
  • 11
  • 10
  • 10
  • 6
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Verwendungszweck

    NLK Rabbit mAb

    Kreuzreaktivität

    Human, Maus, Ratte

    Produktmerkmale

    Monoclonal Antibodies

    Aufreinigung

    Affinity purification

    Immunogen

    Recombinant protein of human NLK.

    Isotyp

    IgG
  • Applikationshinweise

    WB,1:500 - 1:2000,IHC,1:50 - 1:200

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C. Avoid freeze / thaw cycles.
  • Target

    Nemo-Like Kinase (NLK)

    Andere Bezeichnung

    NLK

    Hintergrund

    Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2. Negative regulator of the canonical Wnt/beta-catenin signaling pathway. Binds to and phosphorylates TCF7L2/TCF4 and LEF1, promoting the dissociation of the TCF7L2/LEF1/beta-catenin complex from DNA, as well as the ubiquitination and subsequent proteolysis of LEF1. Together these effects inhibit the transcriptional activation of canonical Wnt/beta-catenin target genes. Negative regulator of the Notch signaling pathway. Binds to and phosphorylates NOTCH1, thereby preventing the formation of a transcriptionally active ternary complex of NOTCH1, RBPJ/RBPSUH and MAML1. Negative regulator of the MYB family of transcription factors. Phosphorylation of MYB leads to its subsequent proteolysis while phosphorylation of MYBL1 and MYBL2 inhibits their interaction with the coactivator CREBBP. Other transcription factors may also be inhibited by direct phosphorylation of CREBBP itself. Acts downstream of IL6 and MAP3K7/TAK1 to phosphorylate STAT3, which is in turn required for activation of NLK by MAP3K7/TAK1. Upon IL1B stimulus, cooperates with ATF5 to activate the transactivation activity of C/EBP subfamily members. Phosphorylates ATF5 but also stabilizes ATF5 protein levels in a kinase-independent manner.,NLK, nemo like kinase,Epigenetics & Nuclear Signaling,Signal Transduction,Kinase,Serine/threonine kinases,Cell Biology & Developmental Biology,Cell Cycle,Wnt/β-Catenin Signaling Pathway,Stem Cells,NLK

    Molekulargewicht

    58kDa

    Gen-ID

    51701

    UniProt

    Q9UBE8

    Pathways

    Ubiquitin Proteasome Pathway
Sie sind hier:
Chat with us!